Though GLP-1 drugs drive major weight loss, researchers warn they may fall short in improving heart and lung fitness. Protecting muscle mass may be key to unlocking their full health potential. Widely used GLP-1 medications are highly effective at promoting significant weight loss, but new research from the University of Virginia suggests they may fall […]



Summary

GLP-1 drugs like Ozempic and Wegovy lead to substantial weight loss, but a recent University of Virginia study indicates they might not significantly improve heart and lung fitness. Researchers found that while participants lost weight on GLP-1s, their cardiovascular fitness gains were modest. The study highlights the potential for muscle loss during GLP-1 treatment and suggests that preserving or building muscle mass could be crucial to maximizing the drugs’ overall health benefits beyond just weight reduction. Future research should explore strategies to enhance fitness and maintain muscle while using GLP-1 medications.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!

Credits: Source

Disclaimer